covid 19 News and Research

RSS

Adequate building ventilation can help tackle airborne transmission of Covid-19

Preventing airborne transmission of Covid-19 should be the next front of the battle against the virus, argue experts from the University of Surrey.

28 May 2020

Women and minorities inadequately represented in clinical trials for novel cardiometabolic drugs

Women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrollment numbers over the past decade, according to new research published last week in the Journal of the American Heart Association, an open-access journal of the American Heart Association.

28 May 2020

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

A transgenic mouse developed at Cincinnati Children's to model the deadly childhood immune disease HLH (hemophagocytic lymphohistiocytosis) may play a key role in saving lives during the COVID-19 virus pandemic.

28 May 2020

Some ivory towers are ideal for a pandemic. Most aren’t.

Saint Mary's College in Moraga, California, is open for business this fall — but to get there, you really have to want it. Tucked amid verdant hills 23 miles east of San Francisco, accessible by a single road and a single entrance, the small, private Roman Catholic school receives almost no visitors by accident.

28 May 2020

Nearly 50% of COVID-19 patients have altered sense of tastes

Nearly half of individuals who contract COVID-19 experience changes in their sense of taste, a new analysis led by a University of Toledo researcher has found.

28 May 2020

PKU-led team identifies potent neutralizing antibodies against SARS-CoV-2

A joint research team led by Sunney Xie, Director of Beijing Advanced Innovation Center for Genomics at Peking University has successfully identified multiple highly potent neutralizing antibodies against the novel coronavirus SARS-CoV-2, the causative virus of the respiratory disease COVID-19, from convalescent plasma by high-throughput single-cell sequencing.

28 May 2020

For seniors, COVID-19 sets off a pandemic of despair

As states relax coronavirus restrictions, older adults are advised, in most cases, to keep sheltering in place. But for some, the burden of isolation and uncertainty is becoming hard to bear.

28 May 2020

Antibody tests were hailed as way to end lockdowns. Instead, they cause confusion.

Aspen was an early COVID-19 hot spot in Colorado, with a cluster of cases in March linked to tourists visiting for its world-famous skiing. Tests were in short supply, making it difficult to know how the virus was spreading.

28 May 2020

Molecular signatures can predict outcome of sepsis patients based on their immune response

Scientists have identified molecular signatures in the immune component of the blood which indicate how patients in intensive care with sepsis, septic shock and systemic inflammatory response syndrome are likely to respond to the conditions.

28 May 2020

Shandong University offers high-tech support to fight against coronavirus epidemic

Since the COVID-19 outbreak, the SDU-NTU Joint Centre for Artificial Intelligence Research has developed two types of robots, which were sent to hospitals in Wuhan and Huanggang in China’s Hubei Province to aid front-line fight against the coronavirus epidemic.

28 May 2020

SCN study outlines impacts of targeted skills training on Canada’s regenerative medicine sector

Today, Canada’s Stem Cell Network (SCN) released a study entitled, Training Tomorrow’s Research Leaders, outlining the impacts of nearly 20 years of targeted skills training on Canada’s emergent regenerative medicine sector.

28 May 2020

SignalChem Biotech Inc. launches COVID-19 elisa kits for diagnostic research

SignalChem, a global leader in cell signaling and protein engineering, has been conducting research on new coronaviruses since the outbreak of the virus.

From SignalChem Biotech Inc. 28 May 2020

Measuring the binding of SARS-CoV-2 antibodies to the COVID spike protein using SPR

Ryan Denomme, the CEO of Nicoya, speaks to News-Medical on their SARS-CoV-2 research using their SPR technology.

From Nicoya Lifesciences 28 May 2020

Clinical trial of COVID-19 vaccine starts in Australia

Over 100 candidate vaccines are being explored as a means of ending the COVID-19 pandemic. Eight of these have already made it to clinical trials in humans, and another 94 are in the pre-clinical evaluation stage.

27 May 2020

Faulty ApoE4 gene increases risk for Alzheimer’s and for COVID-19

It has not been clear whether dementia worsens the infection or if it has resulted from the patient's old age and the severity of care home outbreaks. Now, a new study sheds light on the reason why people with dementia are at a high risk of developing severe disease caused by the coronavirus disease.

27 May 2020

Canadian study of COVID-19 patients admitted to ICUs finds lower overall mortality

A Canadian case series of all patients with COVID-19 admitted to six intensive care units (ICUs) in Metro Vancouver found patient outcomes were substantially better than reported in other jurisdictions. The paper is published in CMAJ.

27 May 2020

Is air pollution a risk factor for COVID-19 infection?

The COVID-19 pandemic began at the very end of 2019 in Wuhan city, Hubei province, China. However, its spread soon began to threaten the health of the whole country and then of the world, leading to nearly 5.7 million cases and over 355,000 dead as of today. A new study, published on the preprint server medRxiv* in May 2020, explores the effects of air pollution on COVID-19 infections in China.

27 May 2020

WVU partnership produces thousands of swabs to meet demands for COVID-19 testing

With significantly increased testing a key component in the battle against COVID-19, the Innovation Hub at West Virginia University is working with WVU Medicine to churn out up to 10,000 swabs weekly to meet demands for tests.

27 May 2020

Research provides guidance for treating pancreatic cancer patients during COVID-19 pandemic

The novel coronavirus (COVID-19) pandemic not only affects patients who have the virus, but strikes the entire healthcare system including the care for patients with cancer.

27 May 2020

SARS-CoV-2 RNA in blood tests not associated with infectious virus

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has challenged hospitals and laboratory services worldwide. Diagnostic testing for SARS-CoV-2 initially lagged but is now primarily based on the use of reverse transcriptase-polymerase chain reaction (RT-PCR) to detect viral nucleic RNA in the samples. However, viral RNA has also been reported in several small series of cases, though its significance and frequency remain unclear.

27 May 2020

covid 19 News and Research

Adequate building ventilation can help tackle airborne transmission of Covid-19

Women and minorities inadequately represented in clinical trials for novel cardiometabolic drugs

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

Some ivory towers are ideal for a pandemic. Most aren’t.

Nearly 50% of COVID-19 patients have altered sense of tastes

PKU-led team identifies potent neutralizing antibodies against SARS-CoV-2

For seniors, COVID-19 sets off a pandemic of despair

Antibody tests were hailed as way to end lockdowns. Instead, they cause confusion.

Molecular signatures can predict outcome of sepsis patients based on their immune response

Shandong University offers high-tech support to fight against coronavirus epidemic

SCN study outlines impacts of targeted skills training on Canada’s regenerative medicine sector

SignalChem Biotech Inc. launches COVID-19 elisa kits for diagnostic research

Measuring the binding of SARS-CoV-2 antibodies to the COVID spike protein using SPR

Clinical trial of COVID-19 vaccine starts in Australia

Faulty ApoE4 gene increases risk for Alzheimer’s and for COVID-19

Canadian study of COVID-19 patients admitted to ICUs finds lower overall mortality

Is air pollution a risk factor for COVID-19 infection?

WVU partnership produces thousands of swabs to meet demands for COVID-19 testing

Research provides guidance for treating pancreatic cancer patients during COVID-19 pandemic

SARS-CoV-2 RNA in blood tests not associated with infectious virus

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News